BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 4
• 5
• 6
• 7
• 8
• 11
• 12
• 13
• 14
• 15
• 18
• 19
• 20
• 21
• 22
• 25
• 26
• 27
• 28
• 29

• Business

  AgriMetis, Isomerase’s Exclusive Crop Protection Relationship

  January 25, 2016

   · 

  1 min read
• Angle’s Parsortix System Demonstrates Notable Performance In The Capture Of Circulating Tumor Cells Versus Other Separation Technologies

  January 25, 2016

   · 

  1 min read
• Pharm Country

  Millennium Healthcare Inc. Announces New Healthcare Product Launch

  January 25, 2016

   · 

  1 min read
• Business

  Kyowa Hakko’s D. Christopher Nolte Promoted To Vice President Of Nutritional Sales

  January 25, 2016

   · 

  1 min read
• Business

  Therapeutics Solutions Licenses Dexosome Clinical Stage Cancer Immunotherapy Product From Gustave Roussy European Cancer Centre

  January 25, 2016

   · 

  3 min read
• Business

  EnGeneIC Pty Ltd Strengthens Board Of Directors To Support U.S. Expansion

  January 25, 2016

   · 

  3 min read
• Business

  Onxeo Announces The Evolution And Reinforcement Of Its Board Of Directors

  January 25, 2016

   · 

  7 min read
• Biotech Bay

  GenePool From Station X To Help Epic Sciences Analyze Circulating Tumor Cell Data

  January 25, 2016

   · 

  1 min read
• Drug Development

  Cytori Therapeutics, Inc. Update On Its U.S. Phase III Scleroderma Trial

  January 25, 2016

   · 

  4 min read
• FDA

  Bristol-Myers Squibb’s Opdivo (Nivolumab) + Yervoy (Ipilimumab) Regimen Receives Expanded FDA Approval In Unresectable Or Metastatic Melanoma Across BRAF Status1

  January 25, 2016

   · 

  1 min read